Clinical Interest of a Genetic Diagnosis in Early Infant Epilepsy, Paraclinical and Therapeutic Management, and Psychological Impact of Families
1 other identifier
observational
75
1 country
1
Brief Summary
To determine the paraclinical and therapeutic interest of genetic diagnosis in early onset epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2022
CompletedFirst Posted
Study publicly available on registry
July 13, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedAugust 12, 2022
August 1, 2022
Same day
July 7, 2022
August 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of event densities
The frequency of events (crises, going to the emergency room, hospitalizations) before and after genetic diagnosis.
4 month
Interventions
Sends and returns questionnaires to families.
Eligibility Criteria
Children aged ≤ 12 years, hospitalized or followed at the Hautepierre Hospital of the University Hospitals of Strasbourg for primary epilepsy having started in the first 5 months of life, from 2010 to 2021.
You may qualify if:
- Children aged ≤ 12 years,
- hospitalized or followed at the Hautepierre Hospital of the University Hospitals of Strasbourg for primary epilepsy having started in the first 5 months of life, from 2010 to 2021.
You may not qualify if:
- \- Children with secondary epilepsy (with infection trauma)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Génétique Médicale IGMA - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2022
First Posted
July 13, 2022
Study Start
August 1, 2022
Primary Completion
August 1, 2022
Study Completion
December 1, 2022
Last Updated
August 12, 2022
Record last verified: 2022-08